rhenium has been researched along with Acute Confusional Senile Dementia in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Barnard, PJ; Donnelly, PS; McLean, CA; Noor, A; Wiratpruk, N | 1 |
| Blower, PJ; Bordoloi, J; Donnelly, PS; Hungnes, IN; Ma, MT; Mota, F; Spyrou, B; White, JM | 1 |
| Gabr, MT; Pigge, FC | 1 |
| Debnath, ML; Klunk, WE; Lin, KS; Mason, NS; Mathis, CA; Pan, J | 1 |
| Barnham, KJ; Donnelly, PS; Hayne, DJ; McLean, CA; Villemagne, VL; White, JM | 1 |
| Barnard, PJ; Chan, CY; Donnelly, PS; McLean, CA; Noor, A | 1 |
| Fuchigami, T; Haratake, M; Ikeoka, R; Kimura, H; Nakayama, M; Ono, M; Saji, H; Watanabe, H | 1 |
| Cui, M; Li, Z; Liu, B; Ren, H; Tang, R | 1 |
| Benaki, D; Papadopoulos, M; Pelecanou, M; Pirmettis, I; Psycharis, V; Raptopoulou, CP; Sagnou, M; Triantis, C; Tsotakos, T | 1 |
| Cheng, Y; Kimura, H; Ono, M; Saji, H; Ueda, M | 1 |
| Papadopoulos, M; Patsis, G; Pelecanou, M; Pirmettis, IC; Raptopoulou, C; Terzis, A; Tzanopoulou, S | 1 |
| Chen, X; Liu, B; Yu, P; Zhang, L | 1 |
| Anguiano, M; Cho, CG; Han, H; Lansbury, PT; Lemere, CA; Zhen, W | 1 |
13 other study(ies) available for rhenium and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Charge neutral rhenium tricarbonyl complexes of tridentate N-heterocyclic carbene ligands that bind to amyloid plaques of Alzheimer's disease.
Topics: Alzheimer Disease; Amines; Amyloid beta-Peptides; Benzothiazoles; Binding Sites; Carboxylic Acids; Coordination Complexes; Humans; Ligands; Molecular Structure; Organotechnetium Compounds; Prefrontal Cortex; Rhenium; Stilbenes | 2020 |
Oxorhenium(V) and Oxotechnetium(V) Complexes of N
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Coordination Complexes; Humans; Ligands; Mice; Organotechnetium Compounds; Peptide Fragments; Pyridines; Radiopharmaceuticals; Rhenium; Styrenes | 2021 |
Rhenium Complexes of Bis(benzothiazole)-Based Tetraarylethylenes as Selective Luminescent Probes for Amyloid Fibrils.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Benzothiazoles; Chelating Agents; Humans; Ligands; Luminescence; Peptide Fragments; Rhenium; Thiazoles | 2018 |
Design, synthesis and structure-activity relationship of rhenium 2-arylbenzothiazoles as β-amyloid plaque binding agents.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Coordination Complexes; Drug Design; Humans; Organotechnetium Compounds; Peptide Fragments; Protein Binding; Radiography; Rhenium; Structure-Activity Relationship; Thiazoles; Tomography, Emission-Computed, Single-Photon | 2013 |
Synthesis of Oxorhenium(V) and Oxotechnetium(V) Complexes That Bind to Amyloid-β Plaques.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Brain; Chemistry Techniques, Synthetic; Crystallography, X-Ray; Humans; Magnetic Resonance Spectroscopy; Molecular Structure; Organotechnetium Compounds; Peptide Fragments; Plaque, Amyloid; Radiopharmaceuticals; Rhenium; Technetium | 2016 |
Rhenium(i) complexes of N-heterocyclic carbene ligands that bind to amyloid plaques of Alzheimer's disease.
Topics: Alzheimer Disease; Coordination Complexes; Frontal Lobe; Humans; Ligands; Methane; Microscopy, Fluorescence; Models, Molecular; Optical Imaging; Plaque, Amyloid; Rhenium | 2017 |
99mTc/Re complexes based on flavone and aurone as SPECT probes for imaging cerebral β-amyloid plaques.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Benzofurans; Brain; Coordination Complexes; Disease Models, Animal; Flavones; Mice; Molecular Probes; Organotechnetium Compounds; Peptide Fragments; Plaque, Amyloid; Radiopharmaceuticals; Rhenium; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2010 |
99mTc- and Re-labeled 6-dialkylamino-2-naphthylethylidene derivatives as imaging probes for β-amyloid plaques.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Coordination Complexes; Mice; Naphthalenes; Organotechnetium Compounds; Radiopharmaceuticals; Rhenium; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2011 |
Curcumin as the OO bidentate ligand in "2 + 1" complexes with the [M(CO)3]+ (M = Re, 99mTc) tricarbonyl core for radiodiagnostic applications.
Topics: Alzheimer Disease; Brain; Carbon Monoxide; Crystallography, X-Ray; Curcumin; Cyclohexanes; Humans; Imidazoles; Nitriles; Organometallic Compounds; Organotechnetium Compounds; Plaque, Amyloid; Radiopharmaceuticals; Rhenium; Technetium | 2011 |
Technetium-99m labeled pyridyl benzofuran derivatives as single photon emission computed tomography imaging probes for β-amyloid plaques in Alzheimer's brains.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Benzofurans; Brain; Chelating Agents; Coordination Complexes; Mice; Mice, Transgenic; Molecular Imaging; Plaque, Amyloid; Pyridines; Radiopharmaceuticals; Rhenium; Structure-Activity Relationship; Technetium; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2012 |
Oxorhenium(V) and oxotechnetium(V) [NN][S]3 complexes of 2-phenylbenzothiazole derivatives.
Topics: Alzheimer Disease; Cell Line, Tumor; Crystallography, X-Ray; Humans; Ligands; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Organometallic Compounds; Organotechnetium Compounds; Oxidation-Reduction; Phenols; Radiopharmaceuticals; Rhenium; Sensitivity and Specificity; Stereoisomerism; Sulfhydryl Compounds; Technetium; Thiazoles | 2006 |
Synthesis and biological evaluation of 99mTc, Re-monoamine-monoamide conjugated to 2-(4-aminophenyl)benzothiazole as potential probes for beta-amyloid plaques in the brain.
Topics: Alzheimer Disease; Amides; Amines; Amyloid beta-Peptides; Animals; Benzothiazoles; Blood-Brain Barrier; Brain; Humans; Isotope Labeling; Male; Mice; Microscopy, Fluorescence; Middle Aged; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Technetium Compounds; Tissue Distribution | 2008 |
Synthesis and amyloid binding properties of rhenium complexes: preliminary progress toward a reagent for SPECT imaging of Alzheimer's disease brain.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Cerebral Cortex; Coloring Agents; Congo Red; Humans; In Vitro Techniques; Organometallic Compounds; Organotechnetium Compounds; Peptide Fragments; Radiopharmaceuticals; Rhenium; Staining and Labeling; Tomography, Emission-Computed, Single-Photon | 1999 |